Comparison Quality of Life between Type of Melasma Outpatient of Dermatovenerology Clinic
AbstractThe impact of melasma was not only about health problems, however, it also about the social impact that becomes a new problem in the management of melasma. This study was aimed to investigate Quality of Life in some type of melasma. This study was a cross-sectional study on 82 patients diagnosed with melasma in the dermatovenerology clinic in two samples of Private hospital from January-April 2019 that was taken by accidental sampling method. All data of this study were analyzed by descriptive analysis, then the quality of life and clinical presentation were analyzed by logarithmic transformations on Melas-QoL and T-independent Test. There are more participants had malar melasma (76.83%) than the centrofacial melasma (23.17%). T-Independent Tests showed that there was no difference in the quality of life among each type of melasma (P-value <0.05). However, there is a significant difference between the perceptions among each type of melasma (P-value = 0.026), where there are more participants who feel disturbed by the centrofacial melasma (84.2%) than malar melasma (58.7%). There is no difference in the quality of life among each type of melasma. However, patients with centrofacial melasma are more disturbed on their skin than malar types.
K. Wolff, L. Goldsmith, S. Katz, B. Gilchrest, A. Paller, and D. Leffell, ‘Hypomelanoses and hypermelanoses’, in Fitzpatrick’s Dermatology in General Medicine, 8th ed., H. Lapeere, B. Boone, S. Sofie, E. Verhaeghe, M. Gele, K. Ongenae, N. Geel, J. Lambert, and L. Brochez, Eds. New York: Mc Graw Hill, 2012, p. 819.
H. Adalatkhah, H. Bazargani, N. Amini-sani, and S. Zeynizadeh, ‘Melasma and its association with different types of nevi in woman: A case-control study’, BMC Dermatol., vol. 8, no. 3, 2008.
A. C. Handel, L. D. B. Miot, and H. A. Miot, ‘Melasma : A clinical and epidemiological review.’, An. Bras. Dermatol., vol. 89, no. 5, pp. 771–782, 2014.
N. K. Jusuf, ‘Pattern of pigmentation disorder in cosmetic dermatology clinic H. Adam Malik General Hospital Medan tahun 2012 - 2015’, J Gen Proced Dermatol Venereol Indones, vol. 2, no. 1, pp. 1–6, 2017.
N. Bagherani, S. Gianfaldoni, and B. Smoller, ‘An overview on melasma’, J. Pigment. Disord., vol. 2, no. 10, pp. 1–18, 2015.
W. H. Lyford, ‘Melasma’, 2017. .
L. Soepardiman, ‘Kelainan pigmen’, in Ilmu Penyakit Kulit dan Kelamin, 7th ed., S. L. S. Menaldi, K. Bramono, and Wresti Indriatmi, Eds. Jakarta: Fakultas Kedokteran Universitas Indonesia, 2015, pp. 342–345.
Melyawati, L. S. Suseno, I. Bernadette, and L. Legiawati, ‘Perkembangan terbaru etiopatogenesis melasma’, Media Derm. Venereol. Indones., vol. 41, no. 3, pp. 133–138, 2014.
O. A. Ogbechie-Godec and N. Elbuluk, ‘Melasma: an Up-to-Date Comprehensive Review’, Dermatology and Therapy. 2017.
S. Walker, M. Shah, V. Hubbard, M. Pradhan, and M. Ghimire, ‘Skin disease is common in rural Nepal: results of a point prevalence study’, Br J Dermatol, no. 158, pp. 334–338, 2008.
Fatmi Eka Putri, ‘Faktor risiko pada pasien melasma di poliklinik kulit dan kelamin RSUP Dr. M. Djamil Padang’, Universitas Andalas Padang, 2016.
J. K. Ikino, D. H. Nunes, V. P. M. da Silva, M. M. Sens, and T. S. Fröde, ‘Melasma and assessment of the quality of life in Brazilian women’, An. Bras. Dermatol., 2015.
D. Tursina, S. Hajar, and C. G. Inggriyani, ‘Hubungan Derajat Keparahan Melasma dengan Kualitas Hidup pada Pasien Melasma di Praktek Swasta Dokter Spesialis Kulit dan Kelamin Kota Banda Aceh’, J. Ilm. Mhs. Kedokt. Medisia, vol. 2, no. 3, pp. 18–23, 2017.
Krupashankar, ‘A cross-sectional, multicentric clinico-epidemiological study of melasma in India’, Dermatol Ther, vol. 4, pp. 71–81, 2014.
M. Augustin, A. K. Langenbrunch, M. Gutknecht, M. A. Radtke, and C. Blome, ‘Quality of Life Measures for Dermatology: Definition, Evaluation, and Interpretation’, Curr Derm Rep, vol. 1, pp. 148–159, 2012.
C. F. Pollo, S. Meneguin, and H. A. Miot, ‘Evaluation Instruments for Quality of Life Related to Melasma: An Integrative Review’, Clinics, vol. 73, no. e65, pp. 1–9, 2018.
T. J. Lieu and A. G. Pandya, ‘Melasma Quality of Life Measures’, Dermatologic Clinics. 2012.
R. Ali, S. Aman, M. Nadeem, and A. H. Kazmi, ‘Quality of Life in Patients of Melasma’, J. Pakistan Assoc. Dermatologist, vol. 23, no. 2, pp. 143–148, 2013.
O. Harumi and C. L. Goh, ‘The effect of melasma on the quality of life in a sample of women living in Singapore’, J. Clin. Aesthet. Dermatol., 2016.
N. N. Noor, Epidemiologi. Bandung: Rinekas Cipta, 2008.
Copyright (c) 2019 American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.